Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Linezolid and vancomycin decrease the therapeutic effect of methylene blue-photodynamic therapy in a mouse model of MRSA bacterial arthritis.

Tanaka M, Mroz P, Dai T, Huang L, Morimoto Y, Kinoshita M, Yoshihara Y, Shinomiya N, Seki S, Nemoto K, Hamblin MR.

Photochem Photobiol. 2013 May-Jun;89(3):679-82. doi: 10.1111/php.12040. Epub 2013 Feb 19.

2.

Photodynamic therapy using intra-articular Photofrin for murine MRSA arthritis: biphasic light dose response for neutrophil-mediated antibacterial effect.

Tanaka M, Kinoshita M, Yoshihara Y, Shinomiya N, Seki S, Nemoto K, Hamblin MR, Morimoto Y.

Lasers Surg Med. 2011 Mar;43(3):221-9. doi: 10.1002/lsm.21037.

3.

Photodynamic therapy induces an immune response against a bacterial pathogen.

Huang YY, Tanaka M, Vecchio D, Garcia-Diaz M, Chang J, Morimoto Y, Hamblin MR.

Expert Rev Clin Immunol. 2012 Jul;8(5):479-94. doi: 10.1586/eci.12.37. Review.

4.

Virulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescence.

Yoshizawa S, Tateda K, Saga T, Ishii Y, Yamaguchi K.

Antimicrob Agents Chemother. 2012 Apr;56(4):1744-8. doi: 10.1128/AAC.05430-11. Epub 2012 Jan 30.

5.

Photodynamic therapy can induce a protective innate immune response against murine bacterial arthritis via neutrophil accumulation.

Tanaka M, Mroz P, Dai T, Huang L, Morimoto Y, Kinoshita M, Yoshihara Y, Nemoto K, Shinomiya N, Seki S, Hamblin MR.

PLoS One. 2012;7(6):e39823. doi: 10.1371/journal.pone.0039823. Epub 2012 Jun 26.

7.

In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides.

Ribes S, Pachón-Ibáñez ME, Domínguez MA, Fernández R, Tubau F, Ariza J, Gudiol F, Cabellos C.

Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1361-7. doi: 10.1007/s10096-010-1007-y. Epub 2010 Aug 1.

8.

Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection.

Liu X, He Y, Xiao K, White JR, Fusco DN, Papanicolaou GA.

PLoS One. 2013;8(3):e57483. doi: 10.1371/journal.pone.0057483. Epub 2013 Mar 5.

9.

Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.

Wunderink RG, Mendelson MH, Somero MS, Fabian TC, May AK, Bhattacharyya H, Leeper KV Jr, Solomkin JS.

Chest. 2008 Dec;134(6):1200-7. doi: 10.1378/chest.08-0011. Epub 2008 Aug 21.

PMID:
18719064
11.

[Antimicrobial and clinical effect of linezolid (ZYVOX), new class of synthetic antibacterial drug].

Irinoda K, Nomura S, Hashimoto M.

Nihon Yakurigaku Zasshi. 2002 Oct;120(4):245-52. Review. Japanese.

PMID:
12425150
12.
13.
14.

In vitro 24-hour time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus.

Singh SR, Bacon AE 3rd, Young DC, Couch KA.

Antimicrob Agents Chemother. 2009 Oct;53(10):4495-7. doi: 10.1128/AAC.00237-09. Epub 2009 Jul 27.

15.

Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages.

Jacqueline C, Broquet A, Roquilly A, Davieau M, Caillon J, Altare F, Potel G, Asehnoune K.

J Infect Dis. 2014 Sep 1;210(5):814-23. doi: 10.1093/infdis/jiu145. Epub 2014 Mar 11.

PMID:
24620024
16.

The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.

Rio-Marques L, Hartke A, Bizzini A.

Microb Drug Resist. 2014 Dec;20(6):539-43. doi: 10.1089/mdr.2014.0059.

PMID:
25010140
17.

[A case of pacemaker-lead infection by linezolid-resistant methicillin-resistant Staphylococcus aureus in a hemodialysis patient].

Kojiro M, Tsuchihashi Y, Ishida M, Furumoto A, Matsuda J, Yanagihara K, Morimoto K, Ariyoshi K.

Kansenshogaku Zasshi. 2012 Nov;86(6):778-83. Japanese.

PMID:
23367855
18.

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.

Tas T, Kucukbayrak A, Hakyemez IN, Mengeloglu FZ, Simavli H, Ozyalvacli G, Erdurmus M.

Cornea. 2013 Jul;32(7):1052-7. doi: 10.1097/ICO.0b013e3182912ffa.

PMID:
23665649
19.

Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration.

Franks Z, Campbell RA, Vieira de Abreu A, Holloway JT, Marvin JE, Kraemer BF, Zimmerman GA, Weyrich AS, Rondina MT.

Thromb Haemost. 2013 Apr;109(4):684-95. doi: 10.1160/TH12-08-0543. Epub 2013 Jan 24.

20.

In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).

Tang HJ, Chen CC, Ko WC, Yu WL, Chiang SR, Chuang YC.

Int J Antimicrob Agents. 2011 Jul;38(1):46-51. doi: 10.1016/j.ijantimicag.2011.02.013. Epub 2011 May 6.

PMID:
21549575

Supplemental Content

Support Center